Ebola Cure: At Last, Nigerian
Government ‘Applies For Japanese
Drug’ – Minister
The Minister of Health, Prof. Onyebuchi
Chukwu, Monday announced that the
country has applied for the Japanese drug for
the treatment of Ebola Virus Disease. The
drug – Favipiravir – was developed by a
subsidiary of Fujifilm Holdings and could be
delivered immediately. The flu treatment
was approved by the Japanese health
ministry in March. Fujifilm spokesman
Takao Aoki said the company was in talks
with United States authorities about starting
clinical testing of Favipiravir for Ebola
treatment.
Aoki had said that developers currently had
enough stock to treat around 20,000 patients.
Apart from the Japanese drug, Chukwu said
the country was also applying for the TKM-
Ebola drug alongside two other vaccines
which has been identified by the Treatment
Research Group. The minister, who spoke at
the opening of the 2nd Emergency National
Council on Health meeting on Ebola Virus
Disease outbreak in Nigeria said, “the
Treatment Research Group (TRG) has been
working hard to identify experimental drugs
like Zmapp, and also make
recommendations to government on further
research on these drugs as well as vaccines
for EVD treatment and prevention.”
“Following the TRG’s recommendation and
in consultation with NAFDAC and NHREC,
Nigeria has indicated interest to participate
in the clinical trials for two candidate EVD
vaccines and are considering a third that
may be added to the list. We have also
applied for experimental drugs such as TKM-
Ebola. The TRG has submitted a detailed
profile and brief on the oral antiviral agent
which the Japanese Government has offered
to make available to affected countries
through the World Health Organization. We
are now considering the profile and brief to
enable us reach a final decision on making it
available to our patients.”
“Our initial knowledge of the agent is that it
has been shown to have strong antiviral
activity against the influenza virus following
phases I and II human trails, it is now going
through phase III clinical trials. It is shown
to have strong antiviral property against
Ebola virus in vitro and in vivo. The fact that
it is considered safe, having passed through
phase I and II clinical trials makes it a good
drug for use in emergency situation as the
EVD.”
Source
Short URL : http://www.osundefender.org/?
p=184653

Hmmmm...

Anything goes.

Panic button...

Ebola Vaccine = EWEDU + Water

xamuel17: Ebola Vaccine = EWEDU + Water

Lol